This complimentary live program is designed to address the challenges of identifying and treating Growth Hormone Deficiency in both pediatric and adult populations, with an emphasis on diagnostic testing, comparing long acting vs. daily medication options, and long-term monitoring.
- Live Webinar Date: Friday, November 6, 2026
- Time: 12:00-12:45 PM EST
11/6/2026
11/6/2027
Upon completion of the program, participants will be able to:
- Recognize the clinical presentations and diagnostic challenges associated with growth hormone deficiency (GHD) in pediatric and adult populations, including appropriate patient selection for testing and interpretation of GH stimulation and IGF-1 results.
- Apply evidence-based strategies for individualized growth hormone replacement therapy, including selection and monitoring of daily and long-acting formulations based on patient characteristics, treatment goals, adherence and satisfaction data, and long-term safety considerations.
- Develop comprehensive longitudinal management plans for patients with GHD through case-based application of monitoring strategies, transition-of-care planning, management of comorbidities and adverse effects, and patient-centered approaches to improve long-term outcomes and quality of life.
The primary target audience for this program is endocrinologists and the endocrine care team, including nurses, nurse practitioners (NPs), physician assistants (PAs), and diabetologists.
View All Rare Endocrine Disease Webinars
Laurence Katznelson, MD
Vice Dean, Medical Education
Melvin Brody Chair in Medical Education
Professor, Department of Medicine (Endocrinology)
Cedars-Sinai Medical Center
This activity is supported by an educational grant from Acendis.